ÂÜÀòÂÒÂ×

Clemens-Michael Smola is an accomplished professional with extensive experience in innovative research and entrepreneurship across various fields, including nanomedicine, clinical research, and automotive solutions. As the Founder and Managing Director of Aerodymax since January 2022, Clemens-Michael focuses on reducing greenhouse gas emissions in the trucking and automotive industry. Concurrently, since March 2020, Clemens-Michael has led the HelpBeatCorona Initiative, developing a data analysis survey to profile COVID-19 symptoms and epidemiology. In academia, Clemens-Michael holds a position at Sigmund Freud University Vienna, overseeing projects related to animal-free research methods and artificial organs, while previously contributing to significant research initiatives at prestigious institutions such as University College London and Columbia University. Educational qualifications include a PhD in Nanomedicine from University College London and a Dr.med.sci in Molecular Medicine from Medical University of Graz.